Skip to content
Disclosery

EXANE DERIVATIVES: DAL position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on DAL, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 15 DAL shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 15 shares
    Change vs previous 13F -3,927 shares

    <0.01% of the 13F portfolio, value $435.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 3,942 shares
    Change vs previous 13F -2,018 shares

    0.04% of the 13F portfolio, value $155,986.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 5,960 shares
    Change vs previous 13F -24,589 shares

    0.06% of the 13F portfolio, value $232,924.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 30,549 shares
    Change vs previous 13F +16,145 shares

    0.32% of the 13F portfolio, value $1,301,744.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 14,404 shares
    Change vs previous 13F +9,994 shares

    0.14% of the 13F portfolio, value $595,331.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 4,410 shares
    Change vs previous 13F -1,648 shares

    0.06% of the 13F portfolio, value $212,925.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 6,058 shares
    Change vs previous 13F +1,244 shares

    0.07% of the 13F portfolio, value $243,603.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 4,814 shares
    Change vs previous 13F not available

    0.05% of the 13F portfolio, value $147,216.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).